Pharma OXIT ApS: Financial statements 2023
CVR: 37757292
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharma OXIT ApS (CVR 37757292) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -9,689 and a net result of DKK -9,689 compared with DKK -16,275 the year before. Equity in the 2023 report amounted to DKK -104,925.
- Gross Profit
- DKK -9,689
- Profit/Loss
- DKK -9,689
- Equity
- DKK -104,925
- Total Assets
- DKK 2,375
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -10 t. | -10 t. | -105 t. | - |
| 2022 | - | -16 t. | -16 t. | -95 t. | - |
| 2021 | - | -5 t. | -5 t. | -79 t. | - |
| 2020 | - | -5 t. | -5 t. | -74 t. | - |
| 2019 | - | -10 t. | -17 t. | -69 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharma OXIT ApS has published its annual report for 2022. Gross profit came to DKK -16,258, and the net result was DKK -16,275.
About Pharma OXIT ApS
Pharma OXIT ApS is a Danish company of the type Anpartsselskab based in Knebel, founded in 2016. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Tom Buris Nielsen. The company is owned by Tom Buris Nielsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,919 and a net result of DKK -7,939 compared with DKK -7,501 the year before. Equity in the 2025 report amounted to DKK -120,365.